MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Late-onset cerebellar ataxia: case report of a new CNV on TTBK2 gene as possible cause of SCA-11

I. Rodríguez (Monterrey, Mexico)

Meeting: 2022 International Congress

Abstract Number: 426

Keywords: Ataxia: Clinical features, Ataxia: Genetics, Spinocerebellar ataxia

Category: Ataxia

Objective: To describe a case of  spinocerebellar ataxia type 11 caused by the copy number variant 43008859_43075833 on the TKKB2 gene

Background: The spinocerebellar ataxias (SCAs) are a group of neurodegenerative diseases that affect not only the cerebellum but also other nervous system structures such as brainstem, spinal cord, or peripheral nerves. According to Harding’s classification, SCAs are classified into three types. Type 3 of SCAs include pure autosomal dominant cerebellar ataxias, the most common group of inherited ataxias. However, in some cases, this type of pure ataxia could coexist with other clinical signs such as tremors, abnormal eye movements, or pyramidal signs. The main cause is a trinucleotide expansion which encodes polyglutamine proteins; however, others can be caused by missense mutations or small insertion/deletion variants. SCA-11 is included in type 3 of SCAs and accounts for less than 1% of autosomal dominant ataxia in Europe. The pathogenic variant involved, is the TTBK2 gene.

Method: We present a case of an adult patient with a SCA, followed by a genetic analysis.

Results: A 68-year-old woman presented with a 10-year history of imbalance and abnormal gait. The patient was previously healthy, and her medical and familiar history was irrelevant. On the physical exam, she showed signs of cerebellar ataxia and hyperreflexia in lower extremities. An approach to exclude acquired causes of cerebellar ataxia was performed, including complete serum blood count, metabolic panel, liver function test, thyroid function tests, vitamin B12 and B1, anti-GAD, anti-gliadin, anti-endomysial and anti-transglutaminase antibodies, autoimmune panel, all of them without any abnormality. The brain MRI showed brainstem and cerebellar atrophy. Exome sequencing, copy number variants, and mitochondrial genome tests were performed. A copy number variant 43008859_43075833 on the TKKB2 gene was detected on chromosome 15 in the genomic location of GRCh37.

Conclusion: We report a case of a copy of number variant not previously reported as pathogenic on TKKB2 gene that can be the cause of spinocerebellar ataxia in our patient.

References: Chen Z, Puzriakova A, Houlden H. Spinocerebellar Ataxia Type 11. 2008 Jul 22 [Updated 2019 Oct 31]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2022.
Houlden, H., Johnson, J., Gardner-Thorpe, C., Lashley, T., Hernandez, D., Worth, P., … Wood, N. W. (2007). Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nature Genetics, 39(12), 1434–1436. doi:10.1038/ng.2007.43
Coarelli G, Brice A, Durr A. Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view. F1000Res. 2018;7:1781. Last updated: 12 NOV 2018
Sullivan R, Yau WY, O’Connor E, Houlden H. Spinocerebellar ataxia: an update. J Neurol. 2019;266(2):533–44.
Jackson, P. K. (2012). TTBK2 Kinase: Linking Primary Cilia and Cerebellar Ataxias. Cell, 151(4), 697–699. doi:10.1016/j.cell.2012.10.027
Mundwiler, A., & Shakkottai, V. G. (2018). Autosomal-dominant cerebellar ataxias. Handbook of Clinical Neurology, 173–185. doi:10.1016/b978-0-444-63233-3.00012-9

To cite this abstract in AMA style:

I. Rodríguez. Late-onset cerebellar ataxia: case report of a new CNV on TTBK2 gene as possible cause of SCA-11 [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/late-onset-cerebellar-ataxia-case-report-of-a-new-cnv-on-ttbk2-gene-as-possible-cause-of-sca-11/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/late-onset-cerebellar-ataxia-case-report-of-a-new-cnv-on-ttbk2-gene-as-possible-cause-of-sca-11/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley